Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Laboratory Corporation of America stock | $266.35

Learn how to easily invest in Laboratory Corporation of America stock.

Laboratory Corporation of America Holdings
NYSE: LH - USD
DIAGNOSTICS & RESEARCH
$290.36
+$7.17 (+2.53%)

Laboratory Corporation of America Holdings is a diagnostics & research business based in the US. Laboratory Corporation of America shares (LH) are listed on the NYSE and all prices are listed in US Dollars. Laboratory Corporation of America employs 70,000 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Laboratory Corporation of America

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – LH – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Laboratory Corporation of America stock price (NYSE: LH)

Use our graph to track the performance of LH stocks over time.

Laboratory Corporation of America shares at a glance

Information last updated 2021-07-23.
Latest market close$266.35
52-week range$170.05 - $284.17
50-day moving average $270.00
200-day moving average $252.56
Wall St. target price$305.92
PE ratio 10.4521
Dividend yield N/A (0%)
Earnings per share (TTM) $26.89

Buy Laboratory Corporation of America shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Laboratory Corporation of America stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Laboratory Corporation of America price performance over time

Historical closes compared with the close of $266.35 from 2021-06-04

1 week (2021-07-18) N/A
1 month (2021-06-29) -3.50%
3 months (2021-04-29) -0.24%
6 months (2021-01-25) N/A
1 year (2020-07-25) N/A
2 years (2019-07-25) N/A
3 years (2018-07-25) N/A
5 years (2016-07-25) N/A

Is Laboratory Corporation of America under- or over-valued?

Valuing Laboratory Corporation of America stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Laboratory Corporation of America's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Laboratory Corporation of America's P/E ratio

Laboratory Corporation of America's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 10x. In other words, Laboratory Corporation of America shares trade at around 10x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Laboratory Corporation of America's PEG ratio

Laboratory Corporation of America's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0682. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Laboratory Corporation of America's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Laboratory Corporation of America's EBITDA

Laboratory Corporation of America's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $4.4 billion.

The EBITDA is a measure of a Laboratory Corporation of America's overall financial performance and is widely used to measure a its profitability.

Laboratory Corporation of America financials

Revenue TTM $15.3 billion
Operating margin TTM 25.63%
Gross profit TTM $5 billion
Return on assets TTM 13.01%
Return on equity TTM 30.96%
Profit margin 17.26%
Book value $102.47
Market capitalisation $27.5 billion

TTM: trailing 12 months

Shorting Laboratory Corporation of America shares

There are currently 1.7 million Laboratory Corporation of America shares held short by investors – that's known as Laboratory Corporation of America's "short interest". This figure is 11.7% up from 1.5 million last month.

There are a few different ways that this level of interest in shorting Laboratory Corporation of America shares can be evaluated.

Laboratory Corporation of America's "short interest ratio" (SIR)

Laboratory Corporation of America's "short interest ratio" (SIR) is the quantity of Laboratory Corporation of America shares currently shorted divided by the average quantity of Laboratory Corporation of America shares traded daily (recently around 723817.09401709). Laboratory Corporation of America's SIR currently stands at 2.34. In other words for every 100,000 Laboratory Corporation of America shares traded daily on the market, roughly 2340 shares are currently held short.

However Laboratory Corporation of America's short interest can also be evaluated against the total number of Laboratory Corporation of America shares, or, against the total number of tradable Laboratory Corporation of America shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Laboratory Corporation of America's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Laboratory Corporation of America shares in existence, roughly 20 shares are currently held short) or 0.0174% of the tradable shares (for every 100,000 tradable Laboratory Corporation of America shares, roughly 17 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Laboratory Corporation of America.

Find out more about how you can short Laboratory Corporation of America stock.

Laboratory Corporation of America's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Laboratory Corporation of America.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Laboratory Corporation of America's total ESG risk score

Total ESG risk: 19.26

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Laboratory Corporation of America's overall score of 19.26 (as at 12/31/2018) is excellent – landing it in it in the 15th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Laboratory Corporation of America is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Laboratory Corporation of America's environmental score

Environmental score: 4.17/100

Laboratory Corporation of America's environmental score of 4.17 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Laboratory Corporation of America is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Laboratory Corporation of America's social score

Social score: 11.07/100

Laboratory Corporation of America's social score of 11.07 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Laboratory Corporation of America is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Laboratory Corporation of America's governance score

Governance score: 13.02/100

Laboratory Corporation of America's governance score puts it squarely in the 7th percentile of companies rated in the same sector. That could suggest that Laboratory Corporation of America is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Laboratory Corporation of America's controversy score

Controversy score: 2/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Laboratory Corporation of America scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Laboratory Corporation of America has, for the most part, managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Laboratory Corporation of America Holdings was last rated for ESG on: 2019-01-01.

Total ESG score 19.26
Total ESG percentile 14.56
Environmental score 4.17
Environmental score percentile 7
Social score 11.07
Social score percentile 7
Governance score 13.02
Governance score percentile 7
Level of controversy 2

Laboratory Corporation of America share dividends

We're not expecting Laboratory Corporation of America to pay a dividend over the next 12 months.

Have Laboratory Corporation of America's shares ever split?

Laboratory Corporation of America's shares were split on a 2:1 basis on 12 May 2002. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Laboratory Corporation of America shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Laboratory Corporation of America shares which in turn could have impacted Laboratory Corporation of America's share price.

Laboratory Corporation of America share price volatility

Over the last 12 months, Laboratory Corporation of America's shares have ranged in value from as little as $170.05 up to $284.17. A popular way to gauge a stock's volatility is its "beta".

LH.US volatility(beta: 1.05)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Laboratory Corporation of America's is 1.0457. This would suggest that Laboratory Corporation of America's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Laboratory Corporation of America overview

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty Testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. In addition, it provides online and mobile applications to enable patients to check test results; patient self-service apps; and online applications for managed care organizations. Further, it offers end-to-end drug development, medical device, and diagnostic development solutions from early-stage research to clinical development and commercial market access. The company primarily serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, and independent clinical laboratories.

Frequently asked questions

What percentage of Laboratory Corporation of America is owned by insiders or institutions?
Currently 0.587% of Laboratory Corporation of America shares are held by insiders and 93.414% by institutions.
How many people work for Laboratory Corporation of America?
Latest data suggests 70,000 work at Laboratory Corporation of America.
When does the fiscal year end for Laboratory Corporation of America?
Laboratory Corporation of America's fiscal year ends in December.
Where is Laboratory Corporation of America based?
Laboratory Corporation of America's address is: 358 South Main Street, Burlington, NC, United States, 27215
What is Laboratory Corporation of America's ISIN number?
Laboratory Corporation of America's international securities identification number is: US50540R4092
What is Laboratory Corporation of America's CUSIP number?
Laboratory Corporation of America's Committee on Uniform Securities Identification Procedures number is: 50540R102

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site